Medtronic’s Jason Weidman recalls the long, bumpy road to getting FDA approval for Symplicity Spiral

This week’s DeviceTalks Weekly is a bit of a retrospective on Medtronic’s Symplicity Spiral Renal Denervation System. It obviously ends on a happy note, and we’ll catch up with Jason Weidman, SVP and president of Medtronic’s Coronary and Renal Denervation business in an interview conducted in January. Thank you to AcuityMD for sponsoring this podcast. www.acuityMD.com. Weidman talked with Co-Host Tom Salemi last month to recap a bit of a history of the program including the dramatic – and successful – conclustion at the FDA. We also draw from an earlier interview Weidman gave to our MedtronicTalks Podcast in 2021. Together, these clips and interviews reflect the time and dedication that ambitious medtech programs require. In the current interview, Weidman also give a glimpse of renal denervation’s future. Other resources Medtech Talk Podcast - https://medtechmvp.com/media/medtech-talk-podcast/Mark-Gelfand-Howard-Levin-Discuss-Coridea-Ardian-and-How-They-re-Innovating-Medtech-Innovation 2021 MedtronicTalks Podcast with Jason Weidman - https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-ge Co-Host Chris Newmarker, executive editor of MassDevice, also discusses his new article – 10 Surgical Robotic Companies that You Need to Know. https://www.massdevice.com/10-surgical-robotics-companies-you-need-to-know-2024/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.